SLRX · Salarius Pharmaceuticals Inc

-

-

Please sign in to comment on SLRX

1 Comment

Admin
4 years, 10 months ago

Salarius Pharmaceuticals, Inc is currently in a long term downtrend where the price is trading 24.8% below its 200 day moving average.

From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.3.

Salarius Pharmaceuticals, Inc's total revenue rose by 42.4% to $1M since the same quarter in the previous year.

Its net income has increased by 99.9% to $-2K since the same quarter in the previous year.

Finally, its free cash flow grew by 47.8% to $-1M since the same quarter in the previous year.

Based on the above factors, Salarius Pharmaceuticals, Inc gets an overall score of 4/5.












© PyInvesting 2026

About    Blog    Influencers   Careers   Contact Us   Disclaimer   Privacy Policy